DEF 14A: Ascend Wellness Holdings Sets Date for Annual Stockholders Meeting

Ascend Wellness Holdings will hold its annual meeting of stockholders virtually on May 3, 2024, to elect directors and ratify the appointment of its independent accounting firm.

Summary

• Ascend Wellness Holdings, Inc. will hold its annual meeting of stockholders on May 3, 2024, at 11:00 a.m. Eastern Time, via live audio webcast.
• The meeting will address the election of six directors, ratification of Macias Gini & O'Connell LLP as the independent registered public accounting firm, and other business.
• Stockholders of record as of March 4, 2024, are entitled to notice and to vote.
• The company is using notice-and-access provisions to reduce mailing costs, with proxy materials available online.
• Proxies must be received by Odyssey Trust Company by April 30, 2024, at 12:00 p.m. Eastern Time.
• The board recommends voting FOR the election of each director nominee and FOR the ratification of the accounting firm.
• The company's authorized capital includes 750,000,000 Class A common shares and 100,000 Class B common shares.
• As of March 4, 2024, there were 209,420,011 Class A common shares and 65,000 Class B common shares outstanding.
• Each Class A share has one vote, and each Class B share has 1,000 votes.
• The company's principal executive office is located in New York, NY.
• The company achieved net revenue of $518.6 million and Adjusted EBITDA of $106.5 million in 2023.
• The company opened six dispensaries and entered the Maryland market in 2023.
• The company launched three new brands: Royale, Tunnel Vision, and Common Goods.

Sentiment

Score: 7

Explanation: The document is a standard proxy statement, which is generally neutral in tone. The positive financial results mentioned contribute to a slightly positive sentiment.

Positives

• The company is providing expanded access and cost savings through a virtual annual meeting.
• The board recommends voting FOR all proposals, indicating confidence in the nominees and the accounting firm.
• The company achieved net revenue of $518.6 million and Adjusted EBITDA of $106.5 million in 2023.
• The company opened six dispensaries and entered the Maryland market in 2023.
• The company launched three new brands: Royale, Tunnel Vision, and Common Goods.

Negatives

• An ABSTAIN vote on Proposal 2 will have the effect of a vote AGAINST that proposal.

Risks

• Failure to register a proxyholder with Odyssey Trust Company will result in the proxyholder not receiving a control number to participate in the Meeting and only being able to attend as a guest.
• Guests will be able to listen to the Meeting but will not be able to vote.
• If stockholders fail to ratify the appointment of MGO, the Audit Committee will reconsider whether or not to retain that firm, but it retains sole responsibility for appointing and terminating the independent registered public accounting firm.

Future Outlook

The document does not contain specific forward-looking statements beyond the routine business to be conducted at the annual meeting.

Industry Context

The document provides information relevant to the governance and operational aspects of Ascend Wellness Holdings, a company in the cannabis industry. The company's performance metrics, such as revenue and EBITDA, are key indicators of its competitive position within the industry.

Comparison to Industry Standards

• The document does not provide enough information to make a detailed comparison to industry standards.
• To assess Ascend Wellness's performance against industry benchmarks, one would need to compare its revenue growth, EBITDA margins, and other financial metrics against those of its peers, such as Curaleaf, Green Thumb Industries, and Trulieve.
• Additionally, comparing its corporate governance practices to those of other publicly traded cannabis companies would provide a more comprehensive assessment.

Management Changes

Related Party Transactions

• The Company issued a secured promissory note to a retail dispensary license holder in Massachusetts providing up to $3.5 million of funding.
• The borrower is partially owned by an entity that is managed, in part, by Abner Kurtin, our Executive Chairman.
• The Company transacts with the borrower, as a retail dispensary, in the ordinary course of business.

Stakeholder Impact

• Shareholders are asked to vote on key decisions regarding the company's leadership and governance.
• Employees are indirectly affected by the decisions made at the annual meeting, as they impact the overall direction and stability of the company.
• Customers and suppliers may be indirectly affected by the company's strategic decisions and financial performance.

Next Steps

• Stockholders should review the proxy statement and vote on the proposals.
• The company will hold its annual meeting on May 3, 2024.
• The company will continue to operate its business and pursue its strategic goals.

Key Dates

Keywords

annual meeting, proxy statement, directors, stockholders, Ascend Wellness, cannabis